Literature DB >> 3994187

Reactivation of chronic type B hepatitis presenting as acute viral hepatitis.

G L Davis, J H Hoofnagle.   

Abstract

Three asymptomatic chronic carriers of hepatitis B surface antigen, who had normal serum aminotransferase levels and no detectable hepatitis B e antigen in serum, developed icteric, symptomatic acute hepatitis. Serologic evidence of acute infection with hepatitis A virus, delta hepatitis virus, cytomegalovirus, or Epstein-Barr virus was absent. However, hepatitis B virus DNA and DNA polymerase activity, which were not detectable before the exacerbation, appeared in the serum of all three patients during the acute illness, confirming the diagnosis of spontaneous reactivation of chronic type B hepatitis. Thus, acute exacerbations of chronic type B hepatitis may present as an acute hepatitis superimposed on the chronic carrier state.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3994187     DOI: 10.7326/0003-4819-102-6-762

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Early entecavir treatment for chronic hepatitis B with severe acute exacerbation.

Authors:  Wei-Lun Tsai; Po-Hung Chiang; Hoi-Hung Chan; Huey-Shyan Lin; Kwok-Hung Lai; Jin-Shiung Cheng; Wen-Chi Chen; Feng-Woei Tsay; Huay-Min Wang; Tzung-Jiun Tsai; Hsien-Chung Yu; Ping-I Hsu
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

Review 2.  Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2013-10-17

3.  Acute delta superinfection in a previously unrecognised HBsAg carrier with transient loss of HBsAg simulating acute non-A, non-B hepatitis.

Authors:  C M Chu; Y F Liaw
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

4.  Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation.

Authors:  E A Pariente; A Goudeau; F Dubois; C Degott; E Gluckman; A Devergie; C Brechot; C Schenmetzler; J Bernuau
Journal:  Dig Dis Sci       Date:  1988-09       Impact factor: 3.199

5.  A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group.

Authors:  J Rakela; J W Mosley; V M Edwards; S Govindarajan; E Alpert
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

6.  The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers.

Authors:  K Fujiwara; O Yokosuka; T Ehata; W L Chuang; F Imazeki; H Saisho; M Omata
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

Review 7.  Hepatitis B virus and hepatitis C virus dual infection.

Authors:  Gaia Caccamo; Francesca Saffioti; Giovanni Raimondo
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 8.  Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation.

Authors:  G M Woolf; L M Petrovic; S E Rojter; F G Villamil; L Makowka; L G Podesta; L S Sher; L Memsic; J M Vierling
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

9.  Chronic liver disease rarely follows acute hepatitis B in non-immunocompromised adults.

Authors:  A Roumeliotou; G Papaevangelou
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

10.  Acute hepatitis B or exacerbation of chronic hepatitis B-that is the question.

Authors:  Efrat Orenbuch-Harroch; Liran Levy; Eldad Ben-Chetrit
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.